Items tagged with Diagnostics
‘Test and treat’ is being used to tackle HIV. Why not TB? (post)
Worldwide, tuberculosis (TB) remains a significant cause of disease and deaths. Around 9.9 million people had the disease in 2020. The burden is higher in low- and middle-income countries. Africa accounts for 25% of TB cases.
WHO announces updates on new TB antigen-based skin tests for the diagnosis of TB infection (post)
04 April 2022 | Geneva: Tuberculosis antigen-based skin tests (TBST), a new class of tests to diagnose TB infection, have been evaluated by the World Health Organization (WHO) and are found to be accurate, acceptable, feasible and cost-effective. These tests represent an alternative to tuberculin skin test (TST) and Interferon-Gamma Release Assays (IGRAs).
TB courses at the McGill Summer Institutes (post)
The McGill Summer Institutes in Global Health announced its 2022 TB summer courses. You can submit your application now! Prices increase after 6 May 2022.
WHO announces updates on optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex (post)
12 April 2022 | Geneva: The broth microdilution plate method represents a promising solution for comprehensive and quality-assured phenotypic drug susceptibility testing in tuberculosis (TB). Using this method up to 12 anti-TB agents can be tested simultaneously providing quantitative levels of resistance and aid individualized patient treatment decisions. The document provides an optimized plate design and standardized methodology to facilitate the improvement of the method for clinical use. The World Health Organization (WHO) calls on manufacturers to take forward this optimized method and make it available for programmatic use in resource-limited settings.
Webinar: From evidence to action: Community-led monitoring for access to TB screening and diagnostic testing (post)
Treatment Action Group and the Coalition of Women Living with HIV and AIDS (COWLHA) will host a webinar on 4 May 2022 explaining how community-led monitoring can be used to generate evidence for advocacy to improve the availability, accessibility, acceptability, and quality of TB screening and diagnostic services.
South Africa: Promising early signs from mobile X-ray TB screening pilots (post)
One of the most intriguing findings from South Africa’s first National TB Prevalence Survey was that out of 234 people found to have TB, 58% had abnormal chest X-rays without experiencing any TB symptoms. The short report in which the findings were made public recommended the expanded use of X-ray technology for TB screening.
Molecular tests for TB: A Cochrane review (post)
Global rollout of rapid molecular tests for TB over the last 12 years: Cochrane Review summarizes research on recipient and provider views
WHO: Call for expressions of interest (post)
The World Health Organization (WHO) is seeking expressions of interest from individuals or entities with relevant expertise to perform a systematic review of the evidence for the diagnostic accuracy of targeted next-generation sequencing technologies for detection of drug resistance among people diagnosed with TB.
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure (post)
-- Almost half of the world’s population has no or limited access to diagnostics
-- This situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIV
-- New partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treated
Webinar: From evidence to action: Community-led monitoring for access to TB screening and diagnostic testing - materials now available online (post)
On 4 May 2022, Treatment Action Group (TAG) and the Coalition of Women Living with HIV and AIDS (COWLHA) hosted a webinar on how community-led monitoring can be used to generate evidence for advocacy to improve the availability, accessibility, acceptability, and quality of TB screening and diagnostic services.
Page 45 of 68 · Total posts: 0
←First 44 45 46 Last→